People with heart disease who receive a shingles vaccine saw a 46% cut in major cardiac events and a 66% cut in deaths within a year, a study presented at the American College of Cardiology’s Annual Scientific Session found.
Researchers used TriNetX data for more than 246,800 U.S. adults older than age 50 who had atherosclerotic disease between 2018 and 2025. Half of the study participants received at least one dose of the Shingrix or Zostavax vaccine.
In addition to cutting deaths, the vaccine was linked to a 32% reduced risk of heart attack, 25% reduced risk of stroke and 25% reduced risk of heart failure.
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
